New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

NCT04564157 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Adjuvant Chemotherapy

Interventions

DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Nivolumab

Sponsor

Fundación GECP